The production of chemical and pharmaceutical products in Germany has seen significant fluctuations over the past decade. From 2013 to 2023, the market exhibited periods of growth, decline, and recovery. The industry peaked in value at €216.49 billion in 2021, followed by a slight decline and subsequent recovery to €201.35 billion in 2023. The year-on-year variations indicate volatility, with notable declines in 2019 and 2020, and a remarkable 34.12% increase in 2021. The compound annual growth rate (CAGR) over the last five years remains modest at 0.22%, reflecting overall stagnation in recent times.
Noteworthy year-on-year insights:
- 2019: -5.45% YoY
- 2020: -14.27% YoY
- 2021: +34.12% YoY
- 2022: -8.03% YoY
- 2023: +1.13% YoY
The forecasted data from 2024 to 2028 suggests a consistent upward trend, growing from €205.21 billion in 2024 to €214.23 billion in 2028, with a projected 5-year CAGR of 0.86%. This indicates a steady recovery and potential growth in the industry.
Future trends to watch for include advancements in pharmaceutical innovation, increased emphasis on sustainable chemical production, and potential impacts of regulatory changes. The industry's ability to adapt to these trends will be crucial for sustained growth.
